中国医疗机构药品评价与遴选快速指南(第二版)

标题: 中国医疗机构药品评价与遴选快速指南(第二版)
title: A Quick Guidelien for Drug Evaluation and Selection in Chinese Medical Institutions(2nd Edition)
版本: 更新版
version: Updated
分类: 快速建议指南
classification: Rapid advice guideline
领域: 其他
field: Others
国家和地区: 中国
Country and region: China
指南使用者: 医疗机构药事管理与药物治疗学委员会(小组)、药师、医师等相关人员及相关政府部门制定药物物政策的技术参考。
Guide users: 医疗机构药事管理与药物治疗学委员会(小组)、药师、医师等相关人员及相关政府部门制定药物物政策的技术参考。
证据分级方法: GRADE分级
Evidence grading method: GRADE
制定单位: 首都医科大学附属北京天坛医院
Formulating unit: Department of Pharmacy Beijing Tiantan Hospital Affiliated to Capital Medical University
注册时间: 2022-06-01
Registration time:
注册编号: IPGRP-2022CN301
Registration number:
指南制订的目的: 为指导医疗机构开展药品评价与遴选,增强人民群众获得感、安全感、幸福感,针对《国家基本药物目录》、《国家基本医疗保险、工伤保险和生育保险药品目录》(以下简称《国家医保目录》)内的药品以及新上市药品,应用国内外领先、权威的技术和方法,进行科学评价与遴选,合理制定医疗机构《基本用药供应目录》和《处方集》,促进临床合理用药。
Purpose of the guideline: To guide medical institutions to carry out the drug evaluation and selection process, to enhance people's feeling, a sense of security, happiness, for the catalog of national essential drugs and the national basic medical insurance, inductrial injury insurance and maternity insurance drug catalogue (hereinafter referred to as the catalog of national medical insurance) of drugs and new drugs, leading application at home and abroad, the authority of the technology and method, Scientific evaluation and selection were carried out, and "Essential Drug Supply Catalogue" and "Prescription Collection" were formulated reasonably in medical institutions to promote rational clinical drug use.